SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-448574
Filing Date
2016-02-03
Accepted
2016-02-03 09:54:32
Documents
81
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q d105198d10q.htm 10-Q 422167
2 EX-10.1 d105198dex101.htm EX-10.1 7161
3 EX-31.1 d105198dex311.htm EX-31.1 8448
4 EX-31.2 d105198dex312.htm EX-31.2 8687
5 EX-32.1 d105198dex321.htm EX-32.1 4286
  Complete submission text file 0001193125-16-448574.txt   3528633

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mygn-20151231.xml EX-101.INS 675774
7 XBRL TAXONOMY EXTENSION SCHEMA mygn-20151231.xsd EX-101.SCH 46764
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20151231_cal.xml EX-101.CAL 87168
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20151231_def.xml EX-101.DEF 119789
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20151231_lab.xml EX-101.LAB 344147
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20151231_pre.xml EX-101.PRE 254086
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 161383457
SIC: 2835 In Vitro & In Vivo Diagnostic Substances